Companies

CARGO Therapeutics Inc

NASDAQ: CRGX
$4.47
â–² $0.00 (+0.00%) today
Markets closed · 4:28pm ET
Today · % change

About Cargo Therapeutics

CARGO Therapeutics Inc is a trailblazer in the biotechnology sector, focusing on developing advanced treatments for cancer through chimeric antigen receptor (CAR) T-cell therapies. Its flagship project, CRG-022, aims to combat B-cell malignancies by targeting CD22, a crucial tumor antigen. Additionally, the company is working on CRG-023, a pioneering tri-specific CAR T therapy that targets three B-cell antigens simultaneously. Founded in 2019 and based in San Mateo, California, CARGO Therapeutics is dedicated to revolutionizing cancer treatment.

CRGX Coverage